drugset / Trial / NCT05991973
Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas
Phase 2
Completed
44 enrolled
Zhejiang University
The Affiliated Hospital of Medical College, Ningbo University · collabThe First Affiliated Hospital of Zhengzhou University · collab
NaSingle-groupOpen-labelPrevention
Summary
Clinical Study on the Safety and Effectiveness of low-dose chidamide maintenance therapy after allogeneic hematopoietic stem cell transplantation for T-cell acute lymphoblastic leukemia or T-cell lymphomas.
Timeline
- Start
- 2023-07-15
- Primary completion
- 2025-06-01
- Completion
- 2025-07-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tucidinostat | Small molecule | 10 mg | — |